• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Jinlin, YUAN Yaozuo, ZHANG Ya, ZHAO Shuqiang, ZHAO Xun, ZHANG Mei. Consistency evaluation of domestic generic rifampicin capsules and reference drug in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(5): 603-609. DOI: 10.11665/j.issn.1000-5048.20180513
Citation: ZHANG Jinlin, YUAN Yaozuo, ZHANG Ya, ZHAO Shuqiang, ZHAO Xun, ZHANG Mei. Consistency evaluation of domestic generic rifampicin capsules and reference drug in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(5): 603-609. DOI: 10.11665/j.issn.1000-5048.20180513

Consistency evaluation of domestic generic rifampicin capsules and reference drug in vitro

More Information
  • This study was to evaluate quality consistency of domestic generic and reference preparations. Content and related substances of domestic generic preparations and reference preparation were inspected according to Chinese Pharmacopeia 2015. Then the basic solution for determining dissolution curve was established through preliminary experiment and validation for determination. The dissolution curves of domestic rifampicin capsules and reference preparation were compared in four dissolution mediums: HCl(pH 1. 2), PBS(pH 4. 0), PBS(pH 6. 8)and pure water, respectively. Results showed that the content and related substances of domestic generic and reference preparations complied with the quality standard, but impurity profile displayed that impurities in domestic generic preparations were less than those in the reference preparation, with the content of rifampin quinine being especially less. Furthermore, dissolution of domestic generic and reference preparations were compared, and their dissolution curves were not similar. It is suggested that consistency between domestic rifampicin capsules and reference preparation should be evaluated by bioequivalence test.
  • [1]
    Duan ZH.Research progress of isoniazid and rifampicin on liver toxicity[J].J Mod Med(现代医学),2013,41(6):430-433.
    [2]
    Chinese Pharmacopeia Commission.Chinese Pharmacopeia:part 2(中华人民共和国药典:二部)[S].Beijing:China Medical Science Press,2015:498-499.
    [3]
    The United States Pharmacopieial Convention.The United States Pharmacopeia[S].40th ed.Baltimore:United Book Press,2017:6007-6009.
    [4]
    The British Pharmacopieial Commission.The British Pharmacopeia[S].London:The Stationery Office,2015:1058-1059.
    [5]
    Japanese Pharmacopoeia Commission.The Japanese Pharmacopeia[S].17th ed.Tokyo:Pharmaceutical and Medical Device Regulatory Science Society of Japan,2017:1518-1520.
    [6]
    European Pharmacopoeia Commission.European Pharmacopeia 9.0:volume Ⅱ[S].France:European Directorate for the Quality of Medicines & HealthCare,2017:3489-3490.
    [7]
    Yu QH.Consistency evaluation of generic drug in our country and original drug[J].Shanghai Med Pharm J(上海医药),2013,34(5):35-37.
    [8]
    Becker C,Dressman JB,Junqinqer HE,et al.Biowaiver monographs for immediate release solid oral dosage forms:rifampicin[J].J Pharm Sci,2009,98(7):2252-2267.
  • Related Articles

    [1]WANG Jing, LIU Hongxia, CAI Dongcheng, HE Chaoyong. Advances in pancreatic β-cell protective strategies[J]. Journal of China Pharmaceutical University, 2020, 51(5): 622-627. DOI: 10.11665/j.issn.1000-5048.20200515
    [2]ZHAO Mengqi, LIAO Hong. Researches progress of the relationship between neuro-inflammation and cognitive function[J]. Journal of China Pharmaceutical University, 2019, 50(4): 497-504. DOI: 10.11665/j.issn.1000-5048.20190416
    [3]YU Haiyang, CHEN Song, XU Zheng, GAO Xiangdong, YAO Wenbing. Protective effect of fibroin peptides on Aβ25-35-induced injury in SH-SY5Y cells and its mechanism[J]. Journal of China Pharmaceutical University, 2017, 48(5): 609-613. DOI: 10.11665/j.issn.1000-5048.20170517
    [4]LI Yuyao, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor ADT-OH derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(3): 276-281. DOI: 10.11665/j.issn.1000-5048.20170304
    [5]WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205
    [6]ZHAO Meishun, CHEN Jingrong, ZHENG Yaojie, YANG Hong. Protective effect of genistein on Aβ25-35-induced PC12 cells injury[J]. Journal of China Pharmaceutical University, 2014, 45(2): 227-231. DOI: 10.11665/j.issn.1000-5048.20140217
    [7]WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403
    [8]SHEN Yu. Perspectives on current protection system of traditional Chinese medicine[J]. Journal of China Pharmaceutical University, 2011, 42(2): 189-192.
    [9]Experimental Research of YZH on the Hepatic Protection[J]. Journal of China Pharmaceutical University, 2001, (6): 40-43.
    [10]Synthesis and Nerve Cell Protection Activities of Tetrahydro-acridine Der Ivatives[J]. Journal of China Pharmaceutical University, 2000, (6): 3-7.

Catalog

    Article views (864) PDF downloads (1298) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return